These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26795441)

  • 1. Barbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials.
    Mo Y; Thomas MC; Karras GE
    J Crit Care; 2016 Apr; 32():101-7. PubMed ID: 26795441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phenobarbital monotherapy to a benzodiazepine-based regimen for management of alcohol withdrawal syndrome in trauma patients.
    Fleenor LM; Beavers JR; Tidwell WP; Atchison L; Woo E; Medvecz AJ; Beyene RT; Kast K; Marcovitz D; Dennis BM; Guillamondegui OD; Smith MC
    J Trauma Acute Care Surg; 2024 Mar; 96(3):493-498. PubMed ID: 37599414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Barbiturates for Alcohol Withdrawal Syndrome.
    Martin K; Katz A
    Psychosomatics; 2016; 57(4):341-7. PubMed ID: 27207572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.
    Wong A; Benedict NJ; Armahizer MJ; Kane-Gill SL
    Ann Pharmacother; 2015 Jan; 49(1):14-9. PubMed ID: 25325907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Phenobarbital in Alcohol Withdrawal Management - A Retrospective Comparison Study of Phenobarbital and Benzodiazepines for Acute Alcohol Withdrawal Management in General Medical Patients.
    Nisavic M; Nejad SH; Isenberg BM; Bajwa EK; Currier P; Wallace PM; Velmahos G; Wilens T
    Psychosomatics; 2019; 60(5):458-467. PubMed ID: 30876654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Severe Alcohol Withdrawal.
    Schmidt KJ; Doshi MR; Holzhausen JM; Natavio A; Cadiz M; Winegardner JE
    Ann Pharmacother; 2016 May; 50(5):389-401. PubMed ID: 26861990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital for Acute Alcohol Withdrawal Management in Surgical Trauma Patients-A Retrospective Comparison Study.
    Nejad S; Nisavic M; Larentzakis A; Dijkink S; Chang Y; Levine AR; de Moya M; Velmahos G
    Psychosomatics; 2020; 61(4):327-335. PubMed ID: 32199629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome.
    Nishimura Y; Choi H; Colgan B; Kistler H; Mercado F
    Eur J Intern Med; 2023 Jun; 112():52-61. PubMed ID: 36935249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
    Barrons R; Roberts N
    J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of phenobarbital based approach in treating patient with alcohol withdrawal syndrome: A systematic review and meta-analysis.
    Pourmand A; AlRemeithi R; Kartiko S; Bronstein D; Tran QK
    Am J Emerg Med; 2023 Jul; 69():65-75. PubMed ID: 37060631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients.
    Jaeger TM; Lohr RH; Pankratz VS
    Mayo Clin Proc; 2001 Jul; 76(7):695-701. PubMed ID: 11444401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Should We Phenobarb-it-All?" A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal.
    Wang M; Falank C; Simboli V; Ontengco JB; Spurling B; Rappold J; Chung B; Smith KE
    Am Surg; 2024 Jun; 90(6):1531-1539. PubMed ID: 38574377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenobarbital and/or benzodiazepines for recurrent alcohol withdrawal: A self-controlled, retrospective cohort study.
    Staidle A; Geier C
    Am J Emerg Med; 2022 Apr; 54():263-266. PubMed ID: 35219012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.